Murr Magdalena, Mettenleiter Thomas
Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Methods Mol Biol. 2024;2786:51-87. doi: 10.1007/978-1-0716-3770-8_3.
Vectored RNA vaccines offer a variety of possibilities to engineer targeted vaccines. They are cost-effective and safe, but replication competent, activating the humoral as well as the cellular immune system.This chapter focuses on RNA vaccines derived from negative-strand RNA viruses from the order Mononegavirales with special attention to Newcastle disease virus-based vaccines and their generation. It shall provide an overview on the advantages and disadvantages of certain vector platforms as well as their scopes of application, including an additional section on experimental COVID-19 vaccines.
载体RNA疫苗为设计靶向疫苗提供了多种可能性。它们具有成本效益且安全,但具有复制能力,可激活体液免疫和细胞免疫系统。本章重点介绍来自单股负链RNA病毒目负链RNA病毒的RNA疫苗,特别关注基于新城疫病毒的疫苗及其制备。它将概述某些载体平台的优缺点及其应用范围,包括关于实验性COVID-19疫苗的附加章节。